
‘Rs 36K for neuro patients, free for those treated by Ortho dept': Safdarjung saw vast differences in cost of spinal implants until last year
Can an implant, given to patients free of cost in one department, cost nearly Rs 36,000 in a different department in the same hospital? At the Centre-run Safdarjung Hospital, that was the case for years.
While spinal implants were provided for free at the Central Institute of Orthopaedics at Safdarjung Hospital, patients not covered under the Ayushman Bharat health insurance scheme had to pay for them if the same surgery was conducted in the hospital's neurosurgery department.
This changed in February 2024, when the neurosurgery department started following the same guidelines that were being followed in the orthopaedics department. Mohd Ashfak (37), a patient who got operated upon in the neurosurgery department in 2023 and had to pay for the implant, has now approached the Central Bureau of Investigation (CBI) with a complaint alleging that he was asked to pay Rs 35,910 for four pedicle screws, four inne (used with the screws) and two rods used during his surgery when the same implant was free in the orthopaedics department.
The CBI spokesperson did not respond to questions regarding the status of the complaint.
Responding to questions posed by The Indian Express, the hospital said, 'Spinal implants have been free since February 2024. Before that, patients covered under the Ayushman Bharat insurance scheme were provided free spinal implants through AMRIT pharmacy, and non-Ayushman Bharat patients had to buy spinal implants.'
Asked why the same implant was provided for free in one department and had to be bought in another, the hospital did not respond. On average, 500 to 600 spinal surgeries are conducted at the neurosurgery department as opposed to 350-400 at the Central Institute of Orthopaedics every year.
In his complaint, Ashfak said he fell from a tree in Delhi in July 2023. He suffered a leg injury and spinal fracture and was rushed to Safdarjung's neurosurgery emergency department, where he was told that he would require surgery. Three days later, he was told to buy spinal implants to be used for surgery.
Ashfak, who works at a meat shop and earns Rs 8,000 per month, lives in Delhi with his wife and four children. He told The Indian Express that he took a loan of Rs 35,000 for the surgery.
He added that during the billing at the hospital, he was told that at the Central Institute of Orthopaedics, the implants are free of cost. He was not informed about this before he bought the implant, he maintained.
Ashfak is not the only patient who had to pay for implants.
Chandrashekhar (48), a security guard in Bihar's Gaya district, also had to pay Rs 35,910 to the hospital for the four screws and two rods.
Chandrashekhar and Mansa have three daughters and a son. 'We had spent all our money on our eldest daughter's wedding… We gradually managed to save money for treatment,' said Mansa, adding that they also borrowed some money from Chandrashekhar's employer and local lenders before reaching Delhi. In all, Mansa said, they spent almost Rs 1.5 lakh on the treatment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Indian Express
28 minutes ago
- New Indian Express
Orissa HC fixes July 17 date to review drainage works
CUTTACK: The Orissa High Court has fixed July 17 to review the drainage upgrade work at the SCB Medical College and Hospital (SCB MCH), Acharya Harihar Post Graduate Institute for Cancer (AHPGIC) and Sardar Vallabhbhai Patel Post Graduate Institute of Pediatrics (Sishu Bhawan), in Cuttack. The bench of Justice SK Sahoo and V Narasingh, which is dealing with PILs on civic issues in Cuttack city, fixed the date after taking on record a report submitted by CMC on rain preparedness for the ensuing monsoon at the three premier medical institutions following the HC's order. According to the report, 80 per cent of the drain desilting work inside SCB MCH campus and AHPGIC completed and the rest will be finished by end of the month. It also stated that a high-power VOLVO pump bearing capacity of 24 HP has been installed for dewatering of storm water from the Sishu Bhawan campus. Another 10 HP pump will be provided, if required, at the time of heavy rains. For construction of drainage facility inside Sishu Bhawan Rs 8.08 crore has already been approved by the Health & Family Welfare department. The internal drainage network will be completed by August 31, 2026, the report said.


New Indian Express
40 minutes ago
- New Indian Express
Karnataka Court orders Rs 13 lakh compensation for nurse over faulty Hepatitis report
UDUPI : A senior nurse from Udupi, 43-year-old Shivakumar Shettigar, lost a job opportunity in Saudi Arabia after a diagnostic error wrongly indicated he had hepatitis C. The faulty report was issued by National CT Scanner and Diagnostic Centre, Mangaluru. Shettigar later tested negative at different facilities and approached the Udupi district Consumer Disputes Redressal Commission, alleging negligence. The court ruled in his favour, holding the diagnostic centre accountable for the career loss and mental trauma caused. The court has ordered the centre to pay a compensation of Rs 13.49 lakh to Shettigar within 45 days. Shettigar told TNIE that he was selected for the post of industrial nurse at United Medical Response Company, Saudi Arabia. He was scheduled to travel in February 2024. As part of the mandatory medical clearance required by the Gulf Cooperation Council (GCC), he underwent a test at GCC notified lab -- National CT Scanner and Diagnostic Centre, Mangaluru, on January 17, 2024. The test falsely showed he was Hepatitis C positive. Shettigar underwent a test the next day at a private lab in Manipal, where the results came back negative. Within a week, he also underwent another test at the district government hospital in Udupi and again tested negative. He alleged that the diagnostic centre in Mangaluru had used a faulty kit and the equipment was not properly maintained.


Time of India
an hour ago
- Time of India
Sickle cell anaemia test kits priced less than Rs 50 in govt's bid to eradicate the disease
New Delhi: Sickle cell anaemia tests have become much more affordable, with the government driving the prices of kits to less than Rs 50 in its bid to make diagnosis accessible and eradicate the inherited blood disorder. Two ICMR centres -- National Institute of Immunohaematology ( NIIH ) in Mumbai and the Centre for Research Management and Control of Haemoglobinopathies (CRHCM) in Nagpur -- have validated 35 point-of-care tests for sickle cell anaemia diagnosis developed by different firms in the past six months. The government has proposed large-scale screening for the blood disorder under the National Sickle Cell Elimination Programme , targeting a population of seven crore. "The initial manufacturer's quote was Rs 350 per test. The Department of Health Research received a request to conduct a health technology assessment to evaluate the cost-effectiveness of sickle cell diagnostic kits," Dr Prabhakar Kedar, a senior scientist at the NIIH, told PTI. The ICMR-National Institute for Research in Reproductive Health, along with PGI Chandigarh and NIIH, conducted a comprehensive assessment and determined that point-of-care tests for sickle cell disease/trait among the high-risk population in India would be cost-effective if procured at Rs 100 per test or below. Following the recommendation, the National Health Mission instructed state health departments to procure the diagnostic kits at a maximum price of Rs 100 per test, Dr Kedar informed. "Through public tendering, the competitive procurement process drove the price of the kits down to Rs 82 per test, significantly below the initial quote, resulting in a saving of Rs 1,857 crore. "Subsequently, NIIH validated new kits and the manufacturer has agreed to sell the kits at less than Rs 50 per test," Dr Kedar stated. To support the fight against sickle cell disease, Dr Prabhakar Kedar (Nodal Officer) at ICMR-NIIH in Mumbai and Dr Naga Muralidhar, scientist, at CRMCH in Chandrapur have been chosen by the government to test and approve the new diagnostic kits. "So far, they have checked and approved 35 different kits, including simple tests that can be done on the spot (like finger-prick tests), lab-based tests and molecular tests that detect the disease at the genetic level," Dr Muralidhar elaborated. Most of these kits were tested and approved within just one month of receiving them, he said and added this fast-track validation has helped ensure that high-quality and accurate test kits are available quickly, especially for use in remote and tribal areas. . Dr Kedar termed these efforts a big boost for the National Sickle Cell Elimination Mission, which aims to eliminate the disease from India by 2047. Sickle Cell Disease is one of the most common inherited blood disorders, primarily affecting individuals in sub-Saharan Africa, the Middle East, India, and parts of the Mediterranean. In India alone, the disease burden is significant, especially among tribal and certain non-tribal populations in Maharashtra, Madhya Pradesh, Chhattisgarh, Odisha, Gujarat, and other central and western states. Dr Kedar said that an estimated over 20 million people in India carry the sickle cell gene, and approximately 1 in every 70 births in some regions is affected by the disease. The disease presents a major public health challenge due to its chronic nature, early onset, and high morbidity if not adequately managed, he said. Beyond physical suffering, individuals with sickle cell disease face social stigma and discrimination. Myths that the disease is contagious or a curse result in isolation, marital issues, and academic or workplace challenges. Children often face bullying, while adults struggle with low self-esteem and mental health problems due to chronic pain, fatigue, and visible symptoms, Dr Kedar added. Addressing these challenges requires culturally sensitive health education, psychosocial support, inclusive school and work policies, and patient empowerment. "Government interventions must ensure legal protection, insurance coverage, and welfare schemes to improve the quality of life and reduce the burden of sickle cell disease," Dr Kedar stressed.